JOHN THOMAS

Profile

First Name

: JOHN

Middle Name

:

Last Name

: THOMAS

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2026-05-28 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-11 
D
OTHER INVESTMENT FUND 
 
 
Equity 
2025-05-01 
D/A
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-03-20 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2025-05-05 
D/A
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-03-20 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-03-20 
D
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-17 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-10-02 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-09-25 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-04-18 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-07-26 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-06-20 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-05-31 
D
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2023-02-19 
D
OTHER TRAVEL 
 
DECLINE TO DISCLOSE 
Debt 
2023-03-31 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-22 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-25 
D
OTHER ENERGY 
 
$1 - $1,000,000 
Equity 
2021-02-08 
D
OTHER BANKING AND FINANCIAL SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-21 
D
OTHER BANKING AND FINANCIAL SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-21 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-11 
D
OTHER TECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2019-11-27 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-23 
D
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-01 
D
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-01 
D
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-01 
D
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-01 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2014-12-23 
D
BIOTECHNOLOGY 
 
$5,000,001 - $25,000,000 
Equity 
2014-12-16 
D
COMMERCIAL BANKING 
NATIONAL COMMERCIAL BANKS [6021] 
DECLINE TO DISCLOSE 
Equity 
2013-03-30 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2012-04-24 
D
COMMERCIAL BANKING 
NATIONAL COMMERCIAL BANKS [6021] 
DECLINE TO DISCLOSE 
Equity 
2012-04-20 
D
CONSTRUCTION 
 
DECLINE TO DISCLOSE 
Debt 
2012-03-01 
D
COMMERCIAL BANKING 
NATIONAL COMMERCIAL BANKS [6021] 
DECLINE TO DISCLOSE 
Equity 
2011-08-26 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-02 
D
COMMERCIAL BANKING 
NATIONAL COMMERCIAL BANKS [6021] 
DECLINE TO DISCLOSE 
Equity 
2011-07-01 
D/A
COMMERCIAL BANKING 
NATIONAL COMMERCIAL BANKS [6021] 
$25,000,001 - $100,000,000 
Equity 
2009-11-27 
D
OTHER 
 
NO REVENUES 
Equity 
2010-08-05 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-03-05 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2010-06-24 
D/A
COMMERCIAL BANKING 
NATIONAL COMMERCIAL BANKS [6021] 
$25,000,001 - $100,000,000 
Equity 
2009-11-27 
D
COMMERCIAL BANKING 
NATIONAL COMMERCIAL BANKS [6021] 
$25,000,001 - $100,000,000 
Equity 
2009-11-27 
D
OTHER HEALTH CARE 
 
$1,000,001 - $5,000,000 
 
2009-10-16 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2009-03-17